Joseph C. English
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joseph C. English has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
Vrusha K. Shah
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
5 shared publications- Jeffrey Chen
University of Pittsburgh School of Medicine, Pittsburgh, USA
4 shared publications Noel Prevost
4 shared publicationsPooja Khera
4 shared publicationsJonhan Ho
Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
3 shared publicationsLaura A. Thornsberry
Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
3 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 12 (1) , e255
Expanding access to dermatologic care: a retrospective analysis comparing teledermatology and in-person management for lichen sclerosus
- 11 February 2026
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 12 (1) , e255
Open AccessExpanding access to dermatologic care: a retrospective analysis comparing teledermatology and in-person management for lichen sclerosus
- Open Access
- 6 February 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 71, 161-166
Use of intravenous and oral sodium thiosulfate for acute treatment and chronic management of nonuremic calciphylaxis: A retrospective case series
- 6 February 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 71, 161-166
Open AccessUse of intravenous and oral sodium thiosulfate for acute treatment and chronic management of nonuremic calciphylaxis: A retrospective case series
- Open Access
- 1 January 2026
- Published by SAGE Publications in Telemedicine Reports
- Vol. 7
Clinical Utility of Store-and-Forward Inpatient Teledermatology for Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Care in the Burn Unit
Background: Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe dermatologic emergencies that require rapid diagnosis and specialized care, but access to inpatient dermatology consults is often limited. While store-and-forward inpatient teledermatology (SAFIT) has been used for triaging suspected cases, its role in ongoing disease management remains unclear. Objective: To characterize the clinical characteristics, treatment, and outcomes of patients with SJS/TEN managed by SAFIT, and to compare these measures according to whether the SAFIT consult occurred before or after burn unit admission. Methods: Retrospective case series of 15 consecutive patients with teledermatologist-confirmed SJS/TEN managed by SAFIT at a tertiary-care burn center. Clinical characteristics, treatment patterns, and patient outcomes were evaluated and compared based on the timing of teledermatology involvement relative to burn unit transfer. Time-to-biopsy after SAFIT consult was measured. Results: The cohort was 60.0% male with a mean age of 45.4 years. Mean SCORTEN was 1.6 ± 0.3, and mean body surface area involvement was 18.8 ± 5.9%. Biopsies were obtained in 93.3% of cases, with a mean time-to-biopsy of 2.5 ± 0.7 h after SAFIT consult. SAFIT initiated transfers to a burn center in 40.0% of cases, while 60.0% received their SAFIT consult after burn unit admission. There were no significant differences between groups in demographics, disease severity, treatment patterns, or clinical outcomes, including mortality, complications, and length of hospitalization. Mortality rates were consistent with expected ranges for SJS/TEN. Conclusion: When combined with burn unit care, SAFIT facilitates timely diagnosis and management of SJS/TEN, with comparable outcomes to prior literature regardless of consult timing. These findings suggest a role for SAFIT in standardizing and expanding access to dermatologic care. Future multicenter studies are warranted.
- 1 January 2026
- Published by SAGE Publications in Telemedicine Reports
- Vol. 7
Open AccessClinical Utility of Store-and-Forward Inpatient Teledermatology for Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Care in the Burn Unit
Background: Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe dermatologic emergencies that require rapid diagnosis and specialized care, but access to inpatient dermatology consults is often limited. While store-and-forward inpatient teledermatology (SAFIT) has been used for triaging suspected cases, its role in ongoing disease management remains unclear. Objective: To characterize the clinical characteristics, treatment, and outcomes of patients with SJS/TEN managed by SAFIT, and to compare these measures according to whether the SAFIT consult occurred before or after burn unit admission. Methods: Retrospective case series of 15 consecutive patients with teledermatologist-confirmed SJS/TEN managed by SAFIT at a tertiary-care burn center. Clinical characteristics, treatment patterns, and patient outcomes were evaluated and compared based on the timing of teledermatology involvement relative to burn unit transfer. Time-to-biopsy after SAFIT consult was measured. Results: The cohort was 60.0% male with a mean age of 45.4 years. Mean SCORTEN was 1.6 ± 0.3, and mean body surface area involvement was 18.8 ± 5.9%. Biopsies were obtained in 93.3% of cases, with a mean time-to-biopsy of 2.5 ± 0.7 h after SAFIT consult. SAFIT initiated transfers to a burn center in 40.0% of cases, while 60.0% received their SAFIT consult after burn unit admission. There were no significant differences between groups in demographics, disease severity, treatment patterns, or clinical outcomes, including mortality, complications, and length of hospitalization. Mortality rates were consistent with expected ranges for SJS/TEN. Conclusion: When combined with burn unit care, SAFIT facilitates timely diagnosis and management of SJS/TEN, with comparable outcomes to prior literature regardless of consult timing. These findings suggest a role for SAFIT in standardizing and expanding access to dermatologic care. Future multicenter studies are warranted.
- Open Access
- 22 August 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 65, 62-64
Abdominal diffuse dermal angiomatosis resolved with panniculectomy
- 22 August 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 65, 62-64
Open AccessAbdominal diffuse dermal angiomatosis resolved with panniculectomy
- Open Access
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 179-184
Asynchronous Teledermatology Reduces Wait Times and Maintains High Adherence to Standard Care for Lichen Planus: A Retrospective Study
Background: Lichen planus (LP) is a chronic inflammatory dermatosis with limited teledermatology data guiding its management. Objective: To assess whether asynchronous teledermatology provides timely, guideline-adherent LP care comparable to in-person visits. Methods: A retrospective study of 102 LP patients seen via asynchronous teledermatology ( n = 45) or in-person ( n = 57) from 2020 to 2024. Variables included demographics, response time, diagnostic concordance, treatment, and follow-up compliance. Results: Teledermatology provided rapid access (mean response time: 15 h) to dermatologic care. Diagnostic concordance between teledermatologists and in-person dermatologists was high (90.5%), while concordance with primary care providers was lower (18.5%, p < 0.001). Teledermatologists followed LP care standards, including hepatitis C virus screening (91.1%) and topical corticosteroid initiation (90%). Black patients used eVisits more frequently than in-person care (38.9% vs. 8.8%, p < 0.01), and follow-up compliance was lower among asynchronous patients (57.8% vs. 92.7%, p < 0.001). Conclusion: Asynchronous teledermatology enables timely, high-quality LP care. However, strategies to improve follow-up are needed, particularly for younger teledermatology patients.
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 179-184
Open AccessAsynchronous Teledermatology Reduces Wait Times and Maintains High Adherence to Standard Care for Lichen Planus: A Retrospective Study
Background: Lichen planus (LP) is a chronic inflammatory dermatosis with limited teledermatology data guiding its management. Objective: To assess whether asynchronous teledermatology provides timely, guideline-adherent LP care comparable to in-person visits. Methods: A retrospective study of 102 LP patients seen via asynchronous teledermatology ( n = 45) or in-person ( n = 57) from 2020 to 2024. Variables included demographics, response time, diagnostic concordance, treatment, and follow-up compliance. Results: Teledermatology provided rapid access (mean response time: 15 h) to dermatologic care. Diagnostic concordance between teledermatologists and in-person dermatologists was high (90.5%), while concordance with primary care providers was lower (18.5%, p < 0.001). Teledermatologists followed LP care standards, including hepatitis C virus screening (91.1%) and topical corticosteroid initiation (90%). Black patients used eVisits more frequently than in-person care (38.9% vs. 8.8%, p < 0.01), and follow-up compliance was lower among asynchronous patients (57.8% vs. 92.7%, p < 0.001). Conclusion: Asynchronous teledermatology enables timely, high-quality LP care. However, strategies to improve follow-up are needed, particularly for younger teledermatology patients.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 216-219
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study
Background: Non-scarring alopecia, including androgenetic alopecia (AGA), alopecia areata (AA), telogen effluvium (TE), and traction alopecia (TA), significantly impacts psychosocial well-being. Access to specialized dermatologic care for these conditions is often limited, particularly in underserved populations. Asynchronous teledermatology has emerged as a potential solution to extend care to these groups. Objective: To evaluate the diagnostic utility and treatment patterns of asynchronous teledermatology for non-scarring alopecia and examine its role in improving care access across diverse populations within the University of Pittsburgh Medical Center (UPMC) network. Methods: A retrospective study of 321 asynchronous teledermatology cases of non-scarring alopecia from 2022 to 2023 was conducted using the UPMC medical record system. Diagnosist, treatment type, and demographic data were analyzed. Longitudinal outcomes and adherence data were not consistently available. Results: AA was the most common diagnosis (59.5%), followed by AGA (26.5%), TE (7.5%), and TA (5.0%). A definitive diagnosis was made remotely in 91.3% of cases; only 8.7% required in-person follow-up. Treatment included over-the-counter therapies such as minoxidil and clobetasol, with prescription medications used for moderate to severe cases. Racial demographics reflected high engagement from Black (22.7%) and Asian (12.9%) patients, with 41.7% of patients residing outside Pittsburgh. Conclusion: Asynchronous teledermatology is an effective tool for diagnosing and managing non-scarring alopecia, facilitating timely intervention and improving access to dermatologic care. Future studies should access patient satisfaction, long-term outcomes, and implementation strategies to further expand equitable teledermatology access.
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 216-219
Open AccessAsynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study
Background: Non-scarring alopecia, including androgenetic alopecia (AGA), alopecia areata (AA), telogen effluvium (TE), and traction alopecia (TA), significantly impacts psychosocial well-being. Access to specialized dermatologic care for these conditions is often limited, particularly in underserved populations. Asynchronous teledermatology has emerged as a potential solution to extend care to these groups. Objective: To evaluate the diagnostic utility and treatment patterns of asynchronous teledermatology for non-scarring alopecia and examine its role in improving care access across diverse populations within the University of Pittsburgh Medical Center (UPMC) network. Methods: A retrospective study of 321 asynchronous teledermatology cases of non-scarring alopecia from 2022 to 2023 was conducted using the UPMC medical record system. Diagnosist, treatment type, and demographic data were analyzed. Longitudinal outcomes and adherence data were not consistently available. Results: AA was the most common diagnosis (59.5%), followed by AGA (26.5%), TE (7.5%), and TA (5.0%). A definitive diagnosis was made remotely in 91.3% of cases; only 8.7% required in-person follow-up. Treatment included over-the-counter therapies such as minoxidil and clobetasol, with prescription medications used for moderate to severe cases. Racial demographics reflected high engagement from Black (22.7%) and Asian (12.9%) patients, with 41.7% of patients residing outside Pittsburgh. Conclusion: Asynchronous teledermatology is an effective tool for diagnosing and managing non-scarring alopecia, facilitating timely intervention and improving access to dermatologic care. Future studies should access patient satisfaction, long-term outcomes, and implementation strategies to further expand equitable teledermatology access.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 23-26
Characteristics and Outcomes of Generalized Pustular Psoriasis Patients Managed Through Inpatient Asynchronous Teledermatology: A Retrospective Study
Inpatient teledermatology (ITD) is a growing telemedicine modality aimed at addressing the shortage of dermatologists in hospitals, particularly for the management of complex skin disorders. Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening condition characterized by widespread sterile pustules and systemic inflammation. Despite advances in targeted therapies, treatment is often limited to traditional agents such as cyclosporine and infliximab, due to restrictions in formulary access and insurance coverage. This study aimed to characterize the clinical features, treatment outcomes, and the impact of ITD on the management of hospitalized GPP patients at the University of Pittsburgh Medical Center (UPMC), with a particular focus on hospitalization duration and time to pustule resolution. A retrospective analysis of 35 patients with pustular skin disorders between January 2015 and August 2024 was conducted. Nine biopsy-confirmed GPP cases requiring hospitalization were included. Data on demographics, comorbidities, treatment regimens, and outcomes were collected. ITD consultations provided recommendations for corticosteroid tapering and immunosuppressive therapy initiation. The cohort included nine patients, predominantly White (88.9%), with a median age of 66 years. Preexisting psoriasis and obesity were the most common comorbidities (55.6%). Leukocytosis was the most frequent lab abnormality (77.8%). The average hospitalization duration was 6.1 ± 3.8 days, and readmission occurred in 33.3% of cases. ITD consultations led to early tapering of systemic corticosteroids and initiation of immunosuppressive therapy (55.6% with cyclosporine and 33.3% with infliximab). Significant pustule improvement was achieved in 16.1 ± 7.5 days, with full resolution in 22.5 ± 17.7 days. ITD significantly reduced hospitalization duration for GPP patients compared with historical controls, likely due to timely therapeutic interventions. While newer biological therapies remain restricted in many hospitals, ITD facilitated the effective use of traditional immunosuppressive therapies, improving patient outcomes. This study supports the integration of ITD in hospital care models, especially in institutions lacking in-house dermatologists. Further research should explore long-term outcomes and the role of ITD in managing other emergent dermatologic conditions.
- 1 January 2025
- Published by SAGE Publications in Telemedicine Reports
- Vol. 6 (1) , 23-26
Open AccessCharacteristics and Outcomes of Generalized Pustular Psoriasis Patients Managed Through Inpatient Asynchronous Teledermatology: A Retrospective Study
Inpatient teledermatology (ITD) is a growing telemedicine modality aimed at addressing the shortage of dermatologists in hospitals, particularly for the management of complex skin disorders. Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening condition characterized by widespread sterile pustules and systemic inflammation. Despite advances in targeted therapies, treatment is often limited to traditional agents such as cyclosporine and infliximab, due to restrictions in formulary access and insurance coverage. This study aimed to characterize the clinical features, treatment outcomes, and the impact of ITD on the management of hospitalized GPP patients at the University of Pittsburgh Medical Center (UPMC), with a particular focus on hospitalization duration and time to pustule resolution. A retrospective analysis of 35 patients with pustular skin disorders between January 2015 and August 2024 was conducted. Nine biopsy-confirmed GPP cases requiring hospitalization were included. Data on demographics, comorbidities, treatment regimens, and outcomes were collected. ITD consultations provided recommendations for corticosteroid tapering and immunosuppressive therapy initiation. The cohort included nine patients, predominantly White (88.9%), with a median age of 66 years. Preexisting psoriasis and obesity were the most common comorbidities (55.6%). Leukocytosis was the most frequent lab abnormality (77.8%). The average hospitalization duration was 6.1 ± 3.8 days, and readmission occurred in 33.3% of cases. ITD consultations led to early tapering of systemic corticosteroids and initiation of immunosuppressive therapy (55.6% with cyclosporine and 33.3% with infliximab). Significant pustule improvement was achieved in 16.1 ± 7.5 days, with full resolution in 22.5 ± 17.7 days. ITD significantly reduced hospitalization duration for GPP patients compared with historical controls, likely due to timely therapeutic interventions. While newer biological therapies remain restricted in many hospitals, ITD facilitated the effective use of traditional immunosuppressive therapies, improving patient outcomes. This study supports the integration of ITD in hospital care models, especially in institutions lacking in-house dermatologists. Further research should explore long-term outcomes and the role of ITD in managing other emergent dermatologic conditions.
- Open Access
- 20 July 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (5) , 993-996
Impact of store-and-forward consumer to physician teledermatology as compared to in-person visits for patients with periorificial dermatitis: A retrospective study
- 20 July 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (5) , 993-996
Open AccessImpact of store-and-forward consumer to physician teledermatology as compared to in-person visits for patients with periorificial dermatitis: A retrospective study
- Open Access
- 22 June 2024
- Published by Elsevier in JAAD International
- Vol. 16, 254-256
Managing rosacea using asynchronous consumer to physician teledermatology as compared to in-person visits: A retrospective study
- 22 June 2024
- Published by Elsevier in JAAD International
- Vol. 16, 254-256
Open AccessManaging rosacea using asynchronous consumer to physician teledermatology as compared to in-person visits: A retrospective study